Explore the words cloud of the PERISCOPE project. It provides you a very rough idea of what is the project "PERISCOPE" about.
The following table provides information about the project.
Coordinator |
STICHTING KATHOLIEKE UNIVERSITEIT
Organization address contact info |
Coordinator Country | Netherlands [NL] |
Project website | http://www.periscope-project.eu |
Total cost | 29˙926˙682 € |
EC max contribution | 21˙000˙000 € (70%) |
Programme |
1. H2020-EU.3.1.7. (Innovative Medicines Initiative 2 (IMI2)) |
Code Call | H2020-JTI-IMI2-2015-03-two-stage |
Funding Scheme | IMI2-RIA |
Starting year | 2016 |
Duration (year-month-day) | from 2016-03-01 to 2021-02-28 |
Take a look of project's partnership.
Pertussis vaccines have been very successful in reducing the global burden of pertussis-related disease. However, in the last decade there has been a rise in pertussis incidence, particularly in vaccinated adolescents and adults in industrialized countries. The increased circulation of B. pertussis (Bp) constitutes a risk for transmission to vulnerable infants and older adults. Additionally, immunity in humans has been shown to wane rapidly after immunization with pertussis vaccines, especially with acellular pertussis (aP) vaccines, suggesting that the improved reactogenicity profile of aP compared to whole cell pertussis vaccines, may be accompanied by differences in duration of immunity. The key objectives of PERISCOPE are to 1. identify biomarkers of protection against Bp colonization and disease; 2. foster scientific innovation and rebuild the ecosystem and technical infrastructure needed in Europe to allow the future evaluation of novel pertussis vaccine candidates and 3. improve understanding of the pathogenesis of Bp infection and its potential impact on the recently observed changes in pertussis epidemiology. To reach these objectives, PERISCOPE brings together a selected group of internationally recognized public and EFPIA partners with strong expertise in clinical trials, immunology, molecular microbiology, human and animal challenge models and bioinformatics. We will initiate a series of (pre)clinical studies and develop harmonized human and animal challenge models, standardized assays and cutting-edge techniques to unravel the innate and adaptive responses to Bp. This will allow us to identify biomarkers of protection and durable immunity. PERISCOPE will thus facilitate the accelerated development and registration of novel pertussis vaccines and/or guide optimal use of vaccination strategies. The introduction of improved pertussis vaccines will help to reduce the global burden of pertussis.
External Project website | Websites, patent fillings, videos etc. | 2020-02-20 17:22:05 |
Summary report on first plenary conference with key stakeholders | Documents, reports | 2020-02-20 17:22:05 |
Dissemination toolkit | Other | 2020-02-20 17:22:05 |
PERISCOPE position paper | Documents, reports | 2020-02-20 17:22:05 |
Take a look to the deliverables list in detail: detailed list of PERISCOPE deliverables.
year | authors and title | journal | last update |
---|---|---|---|
2019 |
Mieszko M. Wilk, Lisa Borkner, Alicja Misiak, Lucy Curham, Aideen C. Allen, Kingston H. G. Mills Immunization with whole cell but not acellular pertussis vaccines primes CD4 T RM cells that sustain protective immunity against nasal colonization with Bordetella pertussis published pages: 169-185, ISSN: 2222-1751, DOI: 10.1080/22221751.2018.1564630 |
Emerging Microbes & Infections 8/1 | 2020-03-05 |
2019 |
Hans de Graaf, Muktar Ibrahim, Alison R Hill, Diane Gbesemete, Andrew T Vaughan, Andrew Gorringe, Andrew Preston, Annemarie M Buisman, Saul N Faust, Kent E Kester, Guy A M Berbers, Dimitri A Diavatopoulos, Robert C Read Controlled Human Infection With Bordetella pertussis Induces Asymptomatic, Immunizing Colonization published pages: , ISSN: 1058-4838, DOI: 10.1093/cid/ciz840 |
Clinical Infectious Diseases | 2020-03-05 |
2017 |
Hans de Graaf, Diane Gbesemete, Andrew R. Gorringe, Dimitri A. Diavatopoulos, Kent E. Kester, Saul N. Faust, Robert C. Read Investigating Bordetella pertussis colonisation and immunity: protocol for an inpatient controlled human infection model published pages: e018594, ISSN: 2044-6055, DOI: 10.1136/bmjopen-2017-018594 |
BMJ Open 7/10 | 2020-02-20 |
2018 |
Lisa Borkner, Alicja Misiak, Mieszko M. Wilk, Kingston H. G. Mills Azithromycin Clears Bordetella pertussis Infection in Mice but Also Modulates Innate and Adaptive Immune Responses and T Cell Memory published pages: , ISSN: 1664-3224, DOI: 10.3389/fimmu.2018.01764 |
Frontiers in Immunology 9 | 2020-02-20 |
2018 |
Thibaut Naninck, Loïc Coutte, Céline Mayet, Vanessa Contreras, Camille Locht, Roger Le Grand, Catherine Chapon In vivo imaging of bacterial colonization of the lower respiratory tract in a baboon model of Bordetella pertussis infection and transmission published pages: , ISSN: 2045-2322, DOI: 10.1038/s41598-018-30896-7 |
Scientific Reports 8/1 | 2020-02-20 |
2018 |
Philippe Denoel, Patricia Londoño-Hayes, Magda Chlebus, Magdalena Rodriguez de Azero Impact of the Innovative Medicines Initiative on vaccine development published pages: 769-770, ISSN: 1474-1776, DOI: 10.1038/nrd.2018.72 |
Nature Reviews Drug Discovery 17/11 | 2020-02-20 |
2018 |
Dimitri A. Diavatopoulos, Kingston H.G. Mills, Kent E. Kester, Beate Kampmann, Marcela Silerova, Ulrich Heininger, Jacques J.M. van Dongen, Robbert G. van der Most, Martijn A. Huijnen, Emilio Siena, Nathalie Mielcarek, Martina M. Ochs, Philippe Denoël, Guy Berbers, Annemarie M. Buisman, Marien I. de Jonge, Craig Fenwick, Andrew Gorringe, Qiushui He, Dominic Kelly, Roger Le Grand, Camille Locht, Françoise Mascart, Jussi Mertsola, Alberto Orfao, Giuseppe Pantaleo, Andrew J. Pollard, Andrew Preston, Robert Read, Peter Sebo, Cecile van Els, Branislav Vecerek, Patricia Londoño-Hayes, Ronald de Groot PERISCOPE: road towards effective control of pertussis published pages: , ISSN: 1473-3099, DOI: 10.1016/s1473-3099(18)30646-7 |
The Lancet Infectious Diseases | 2020-02-20 |
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "PERISCOPE" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "PERISCOPE" are provided by the European Opendata Portal: CORDIS opendata.